This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): ND0801, ND0801 transdermal patch
Description: ND0801 is a proprietary co-formulation of nicotine based on an original discovery that maintains, for the first time, continuous nicotinic stimulation without giving rise to desensitization of the nAChRs. ND0801 is currently being developed as a combination dermal patch.
Additional information available to subscribers only: